Vaccine Injury Compensation Awarded to Firas Ido

Strategic Insights -

In a recent decision, the United States Court of Federal Claims has awarded compensation to Firas Ido under the National Vaccine Injury Compensation Program. The award comes after Ido filed a petition in January 2021, alleging that he suffered from brachial neuritis/plexopathy as a result of a tetanus, diphtheria, and acellular pertussis (Tdap) vaccination and an influenza vaccine. Ido's petition was settled through a joint stipulation with the Secretary of Health and Human Services, with both parties agreeing to a decision awarding compensation.

Key Takeaways:

  • Firas Ido was awarded a lump sum of $10,000.00 through the National Vaccine Injury Compensation Program.
  • Ido alleged that he suffered from brachial neuritis/plexopathy as a result of a Tdap vaccination on June 24, 2019, and an influenza vaccine on November 30, 2022.
  • The Secretary of Health and Human Services denied that Ido's alleged condition was caused or significantly aggravated by the vaccines.
  • Both parties agreed to a joint stipulation settling the issues before the court and awarding compensation to Ido.
  • The stipulation awards a specific amount for all damages that would be available under 42 U.S.C. § 300aa-15(a).
  • The Clerk of the Court is directed to enter judgment herewith.

Statistics:

  • Award amount: $10,000.00
  • Date of Tdap vaccination: June 24, 2019
  • Date of influenza vaccination: November 30, 2022
  • Date of petition filing: January 12, 2021
  • Date of joint stipulation filing: August 5, 2025

Sources:

  • United States Court of Federal Claims, Opinion in Case No. 21-589V (filed August 5, 2025)
  • U.S. Code, Title 42, Section 300aa (codified as amended at 42 U.S.C. SSSS 300aa-10-34)
  • National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755